SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018263
Filing Date
2018-08-01
Accepted
2018-08-01 08:21:32
Documents
56
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20180630.htm 10-Q 1826698
2 EX-10.1 atra-ex101_191.htm EX-10.1 473515
3 EX-10.2 atra-ex102_192.htm EX-10.2 499899
4 EX-10.3 atra-ex103_6.htm EX-10.3 367112
5 EX-10.4 atra-ex104_165.htm EX-10.4 81808
6 EX-31.1 atra-ex311_11.htm EX-31.1 16128
7 EX-31.2 atra-ex312_10.htm EX-31.2 16152
8 EX-32.1 atra-ex321_7.htm EX-32.1 7418
  Complete submission text file 0001564590-18-018263.txt   7387244

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT atra-20180630.xml EX-101.INS 1290376
10 XBRL TAXONOMY EXTENSION SCHEMA atra-20180630.xsd EX-101.SCH 38276
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20180630_cal.xml EX-101.CAL 39150
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20180630_def.xml EX-101.DEF 128739
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20180630_lab.xml EX-101.LAB 323913
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20180630_pre.xml EX-101.PRE 236991
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 18983120
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1